Everolimus-Eluting Platinum Chromium Coronary Stent System
SYNERGY - High-bleeding risk patients and DAPT: implementing the latest clinical evidence into real-world practice
- Evidence for DAPT duration in the context of coronary interventions
- Discuss the potential benefits of bioabsorbable polymer DES in high-bleeding risk patients
- Review of Synergy design and comleted and ongoing DAPT studies
- To understand how to relate trial data into real world practice
Balancing Ischemic Event Risk vs Bleeding Risk & Symposium Introduction.
Prof. Stefan James
Review of ESC DAPT Clinical Update 2017 and Latest Evidence.
Dr. Jose M de la Torre Hernandez
Translating the evidence in daily clinical practice: real-world case examples.
Dr. Andrės Iñiguez Romo